Moderna's current market capitalisation on the Nasdaq bourse is approximately 55 billion USD.
According to my estimates, Moderna's intrinsic worth is 140 billion USD.
Moderna reported yesterday fiscal year 2022 earnings.
The coronavirus COVID 19 revenue boost is fading.
However, I still think Moderna is deeply undervalued, because Moderna is at the forefront of the messenger RNA technology, medicine's latest and most advanced and most promising technology.
No comments:
Post a Comment